35
Thetis Pharmaceuticals raises $1M in Connecticut under Reg D 506(b)
Company raise · Raising · DEEP RIVER, CT · Form D filed 2026-10-13
Thetis Pharmaceuticals LLC, a Connecticut pharmaceutical company, is raising $1M and has sold $560K to 10 investors as of August 2026. The offering remains open with $440K available under Regulation D exemption 506(b).
other
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Gary Mathias | Manager |
| Walter Ogier | Manager |
| Frank C. Sciavolino | Manager |
| Dennis Willson | Manager |
| Fabio Cataldi | Manager |
| David Cook | Manager |
Signed by Gary Mathias, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.